Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Lyadova, I V ^a   Panteleev, A V ^a  

^a CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 17; CYTOKINE;

ARTICLE; CELL DIFFERENTIATION; HUMAN; NONHUMAN; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TUBERCULOSIS; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MOUSE;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LATENT TUBERCULOSIS; LYMPHOCYTE ACTIVATION; MICE; TH1 CELLS; TH17 CELLS; TUBERCULOSIS, PULMONARY;

EID: 84948459411     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/854507     Document Type: Article

References (148)

1. C. E. Barry Jr., H. I. Boshoff, V. Dartois et al., "The spectrum of latent tuberculosis: rethinking the biology and intervention strategies," Nature Reviews Microbiology, vol. 7, no. 12, pp. 845-855, 2009.
2. N.W. Schluger and W. N. Rom, "The host immune response to tuberculosis," American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 3, part 1, pp. 679-691, 1998.
3. J. L. Flynn and J. Chan, "Immunology of tuberculosis," Annual Review of Immunology, vol. 19, pp. 93-129, 2001.
4. W. H. Boom, D. H. Canaday, S. A. Fulton, A. J. Gehring, R. E. Rojas, and M. Torres, "Human immunity to M. tuberculosis: T cell subsets and antigen processing," Tuberculosis, vol. 83, no. 1-3, pp. 98-106, 2003.
5. R. J. North and Y.-J. Jung, "Immunity to tuberculosis," Annual Review of Immunology, vol. 22, pp. 599-623, 2004.
6. S. H. E. Kaufmann, "Tuberculosis: back on the immunologists' agenda," Immunity, vol. 24, no. 4, pp. 351-357, 2006.
7. I. V. Lyadova, "Inflammation and immunopathogenesis of tuberculosis progression," in Understanding Tuberculosis-Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity, P.-J. Cardona, Ed., pp. 19-42, Intech, 2012, http://www.intechopen.com/books/understanding-tuberculosis-analyzing-the-origin-of-mycobacterium-tuberculosis-pathogenicity.
8. A. Dorhoi, S. T. Reece, and S. H. E. Kaufmann, "For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection," Immunological Reviews, vol. 240, no. 1, pp. 235-251, 2011.
9. T. R. Mosmann, H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman, "Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins," The Journal of Immunology, vol. 136, no. 7, pp. 2348-2357, 1986.
10. C. M. Evans and R. G. Jenner, "Transcription factor interplay in T helper cell differentiation," Briefings in Functional Genomics, vol. 12, no. 6, Article ID elt025, pp. 499-511, 2013.
11. J. Zhu, D. Jankovic, A. J. Oler et al., "The transcription factor T-bet is induced by multiple pathways and prevents an endogenous T helper-2 programduring T helper-1 responses," Immunity, vol. 37, no. 4, pp. 660-673, 2012.
12. J. Zhu, H. Yamane, and W. E. Paul, "Differentiation of effector CD4 T cell populations," Annual Review of Immunology, vol. 28, pp. 445-489, 2010.
13. L. Wei, G. Vahedi, H.-W. Sun et al., "Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation," Immunity, vol. 32, no. 6, pp. 840-851, 2010.
14. A. A. Lighvani, D. M. Frucht, D. Jankovic et al., "T-bet is rapidly induced by interferon-γ in lymphoid andmyeloid cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15137-15142, 2001.
15. Z. Mikhak, C. M. Fleming, B. D. Medoff et al., "STAT1 in peripheral tissue differentially regulates homing of antigenspecific Th1 and Th2 cells," Journal of Immunology, vol. 176, no. 8, pp. 4959-4967, 2006.
16. J. Geginat, M. Paroni, S. Maglie et al., "Plasticity of human CD4 T cell subsets," Frontiers in Immunology, vol. 5, article 630, 2014.
17. + T cell polarization in vivo," Immunity, vol. 41, no. 1, pp. 63-74, 2014.
18. J. Ma, T. Chen, J. Mandelin et al., "Regulation of macrophage activation," Cellular and Molecular Life Sciences, vol. 60, no. 11, pp. 2334-2346, 2003.
19. J. L. Flynn, J. Chan, and P. L. Lin, "Macrophages and control of granulomatous inflammation in tuberculosis," Mucosal Immunology, vol. 4, no. 3, pp. 271-278, 2011.
20. G. Weiss and U. E. Schaible, "Macrophage defense mechanisms against intracellular bacteria," Immunological Reviews, vol. 264, no. 1, pp. 182-203, 2015.
21. A. M. Cooper, D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme, "Disseminated tuberculosis in interferon gamma gene-disrupted mice," Journal of Experimental Medicine, vol. 178, no. 6, pp. 2243-2247, 1993.
22. A. M. Cooper, J. Magram, J. Ferrante, and I. M. Orme, "Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis," Journal of Experimental Medicine, vol. 186, no. 1, pp. 39-45, 1997.
23. T. Mogues, M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North, "The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice," The Journal of Experimental Medicine, vol. 193, no. 3, pp. 271-280, 2001.
24. J. D. MacMicking, R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan, "Identification of nitric oxide synthase as a protective locus against tuberculosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 10, pp. 5243-5248, 1997.
25. A.M. Cooper, B. H. Segal, A. A. Frank, S. M. Holland, and I.M. Orme, "Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice," Infection and Immunity, vol. 68, no. 3, pp. 1231-1234, 2000.
26. C. A. Scanga, V. P. Mohan, K. Tanaka, D. Alland, J. L. Flynn, and J. Chan, "The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice," Infection and Immunity, vol. 69, no. 12, pp. 7711-7717, 2001.
27. Y.-J. Jung, R. LaCourse, L. Ryan, and R. J. North, "Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice," The Journal of Experimental Medicine, vol. 196, no. 7, pp. 991-998, 2002.
28. F. Altare, A. Durandy, D. Lammas et al., "Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency," Science, vol. 280, no. 5368, pp. 1432-1435, 1998.
29. S. E. Dorman and S.M. Holland, "Interferon-γ and interleukin-12 pathway defects and human disease," Cytokine and Growth Factor Reviews, vol. 11, no. 4, pp. 321-333, 2000.
30. J.-L. Casanova and L. Abel, "Genetic dissection of immunity to mycobacteria: the human model," Annual Review of Immunology, vol. 20, pp. 581-620, 2002.
31. J. E. Gallant and A. H. Ko, "Cavitary pulmonary lesions in patients infectedwith human immunodeficiency virus," Clinical Infectious Diseases, vol. 22, no. 4, pp. 671-682, 1996.
32. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2," The Journal of Experimental Medicine, vol. 192, no. 3, pp. 347-358, 2000.
33. L. Majlessi, M. Simsova, Z. Jarvis et al., "An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis," Infection and Immunity, vol. 74, no. 4, pp. 2128-2137, 2006.
34. H.-W. Mittrücker, U. Steinhoff, A. Köhler et al., "Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 30, pp. 12434-12439, 2007.
35. M. C. Garcia-Pelayo, V. S. Bachy, D. A. Kaveh, and P. J. Hogarth, "BALB/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL/6 mice but have equivalent protection," Tuberculosis, vol. 95, no. 1, pp. 48S-53S, 2014.
36. S. C. Cowley and K. L. Elkins, "CD4+ T cells mediate IFN-γ-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo," The Journal of Immunology, vol. 171, no. 9, pp. 4689-4699, 2003.
37. A. M. Gallegos, J. W. J. van Heijst, M. Samstein, X. Su, E. G. Pamer, and M. S. Glickman, "A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo," PLoS Pathogens, vol. 7, no. 5, Article ID e1002052, 2011.
38. B. Nandi and S. M. Behar, "Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection," The Journal of Experimental Medicine, vol. 208, no. 11, pp. 2251-2262, 2011.
39. E. Lázár-Molnár, B. Chen, K. A. Sweeney et al., "Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 30, pp. 13402-13407, 2010.
40. D. L. Barber, K. D. Mayer-Barber, C.G. Feng, A. H. Sharpe, and A. Sher, "CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition," The Journal of Immunology, vol. 186, no. 3, pp. 1598-1607, 2011.
41. V. Velu, K. Titanji, B. Zhu et al., "Enhancing SIV-specific immunity in vivo by PD-1 blockade," Nature, vol. 458, no. 7235, pp. 206-210, 2009.
42. C. S. Hirsch, Z. Toossi, C. Othieno et al., "Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy," The Journal of Infectious Diseases, vol. 180, no. 6, pp. 2069-2073, 1999.
43. E. Sahiratmadja, B. Alisjahbana, T. de Boer et al., "Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment," Infection and Immunity, vol. 75, no. 2, pp. 820-829, 2007.
44. J. S. Sutherland, M. K. Lalor, G. F. Black et al., "Analysis of host responses to Mycobacterium tuberculosis antigens in amulti-site study of subjects with different TB and HIV infection states in sub-Saharan Africa," PLoS ONE, vol. 8, no. 9, Article ID e74080, 2013.
45. E. Sahiratmadja, B. Alisjahbana, S. Buccheri et al., "Plasma granulysin levels and cellular interferon-γ production correlate with curative host responses in tuberculosis, while plasma interferon-γ levels correlate with tuberculosis disease activity in adults," Tuberculosis, vol. 87, no. 4, pp. 312-321, 2007.
46. M. Sester, G. Sotgiu, C. Lange et al., "Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis," European Respiratory Journal, vol. 37, no. 1, pp. 100-111, 2011.
47. J. Z. Metcalfe, C. K. Everett, K. R. Steingart et al., "Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis," The Journal of Infectious Diseases, vol. 204, supplement 4, pp. S1120-S1129, 2011.
48. M. Pai, C. M. Denkinger, S. V. Kik et al., "Gamma interferon release assays for detection of Mycobacterium tuberculosis infection," Clinical Microbiology Reviews, vol. 27, no. 1, pp. 3-20, 2014.
49. low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans," PLoSONE, vol. 7, no. 8, Article ID e43733, 2012.
50. H2 hypothesis of T cell-mediated tissue damage," Nature Medicine, vol. 13, pp. 139-145, 2007.
51. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., "The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cell," Cell, vol. 126, no. 6, pp. 1121-1133, 2006.
52. H. Park, Z. Li, X. O. Yang et al., "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17," Nature Immunology, vol. 6, no. 11, pp. 1133-1141, 2005.
53. J. F. Zambrano-Zaragoza, E. J. Romo-Martínez, M. D. J. Durán-Avelar et al., "Th17 cells in autoimmune and infectious diseases," International Journal of Inflammation, vol. 2014, Article ID 651503, 12 pages, 2014.
54. L. Codarri, G. Gyülvészii, V. Tosevski et al., "RORγ3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation," Nature Immunology, vol. 12, no. 6, pp. 560-567, 2011.
55. S. C. Liang, X.-Y. Tan, D. P. Luxenberg et al., "Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides," Journal of Experimental Medicine, vol. 203, no. 10, pp. 2271-2279, 2006.
56. P. Miossec, T. Korn, and V. K. Kuchroo, "Interleukin-17 and type 17 helper T cells," The New England Journal of Medicine, vol. 361, no. 9, pp. 888-898, 2009.
57. H. Zhang, F. Bernuzzi, A. Lleo, X. Ma, and P. Invernizzi, "Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases," Mediators of Inflammation, vol. 2015, Article ID 436450, 12 pages, 2015.
58. P. R. Mangan, L. E. Harrington, D. B. O'Quinn et al., "Transforming growth factor-beta induces development of the T H17 lineage," Nature, vol. 441, no. 7090, pp. 231-234, 2006.
59. R. Nurieva, X.O. Yang, G. Martinez et al., "Essential autocrine regulation by IL-21 in the generation of inflammatory T cells," Nature, vol. 448, no. 7152, pp. 480-483, 2007.
60. J. M. Coquet, S. Chakravarti, M. J. Smyth, and D. I. Godfrey, "Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis," Journal of Immunology, vol. 180, no. 11, pp. 7097-7101, 2008.
61. S. Romagnani, E. Maggi, F. Liotta, L. Cosmi, and F. Annunziato, "Properties and origin of human Th17 cells," Molecular Immunology, vol. 47, no. 1, pp. 3-7, 2009.
62. E. Torrado and A. M. Cooper, "IL-17 and Th17 cells in tuberculosis," Cytokine and Growth Factor Reviews, vol. 21, no. 6, pp. 455-462, 2010.
63. S. L. Gaffen, "Recent advances in the IL-17 cytokine family," Current Opinion in Immunology, vol. 23, no. 5, pp. 613-619, 2011.
64. F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, and S. Romagnani, "Human Th17 cells: are they different from murine Th17 cells?" European Journal of Immunology, vol. 39, no. 3, pp. 637-640, 2009.
65. A. Laurence, C. M. Tato, T. S. Davidson et al., "Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation," Immunity, vol. 26, no. 3, pp. 371-381, 2007.
66. A. Cruz, S. A. Khader, E. Torrado et al., "Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection," The Journal of Immunology, vol. 177, no. 3, pp. 1416-1420, 2006.
67. H17 cells by IL-27," Seminars in Immunology, vol. 23, no. 6, pp. 438-445, 2011.
68. E. Bettelli, Y. Carrier, W. Gao et al., "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells," Nature, vol. 441, no. 7090, pp. 235-238, 2006.
69. V. Santarlasci, L. Maggi, M. Capone et al., "TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells," European Journal of Immunology, vol. 39, no. 1, pp. 207-215, 2009.
70. M. Oukka, "Th17 cells in immunity and autoimmunity," Annals of the Rheumatic Diseases, vol. 67, supplement 3, pp. iii26-iii29, 2008.
71. M. Pelletier, L. Maggi, A. Micheletti et al., "Evidence for a crosstalk between human neutrophils and Th17 cells," Blood, vol. 115, no. 2, pp. 335-343, 2010.
72. W. Ouyang, J. K. Kolls, and Y. Zheng, "The biological functions of T helper 17 cell effector cytokines in inflammation," Immunity, vol. 28, no. 4, pp. 454-467, 2008.
73. P. Schwarzenberger, W. Huang, Y. Peng et al., "Requirement of endogenous stem cell factor and granulocyte-colonystimulating factor for IL-17-mediated granulopoiesis," The Journal of Immunology, vol. 164, no. 9, pp. 4783-4789, 2000.
74. J. Witowski, K. Pawlaczyk, A. Breborowicz et al., "IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GROα chemokine from mesothelial cells," The Journal of Immunology, vol. 165, no. 10, pp. 5814-5821, 2000.
75. H. Hoshino, M. Laan, M. Sjöstrand, J. Lötvall, B.-E. Skoogh, and A. Lindén, "Increased elastase andmyeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo," Journal of Allergy and Clinical Immunology, vol. 105, no. 1, pp. 143-149, 2000.
76. M. Miyamoto, O. Prause, M. Sjöstrand, M. Laan, J. Lötvall, and A. Lindén, "Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways," The Journal of Immunology, vol. 170, no. 9, pp. 4665-4672, 2003.
77. J. K. Kolls and S. A. Khader, "The role of Th17 cytokines in primary mucosal immunity," Cytokine & Growth Factor Reviews, vol. 21, no. 6, pp. 443-448, 2010.
78. P. Schwarzenberger, V. La Russa, A. Miller et al., "IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines," The Journal of Immunology, vol. 161, no. 11, pp. 6383-6389, 1998.
79. P. Ye, F. H. Rodriguez, S. Kanaly et al., "Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense," The Journal of Experimental Medicine, vol. 194, no. 4, pp. 519-527, 2001.
80. Y. Chen, P. Thai, Y.-H. Zhao, Y.-S. Ho, M. M. DeSouza, and R. Wu, "Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop," The Journal of Biological Chemistry, vol. 278, no. 19, pp. 17036-17043, 2003.
81. C.-Y. Kao, Y. Chen, P. Thai et al., "IL-17markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κB signalingpathways," The Journal of Immunology, vol. 173, no. 5, pp. 3482-3491, 2004.
82. H.-C. Tsai, S. Velichko, L.-Y. Hung, and R. Wu, "IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection," Clinical and Developmental Immunology, vol. 2013, Article ID 267971, 12 pages, 2013.
83. A. Li, Y. Gan, R. Wang et al., "IL-22 up-regulates β-defensin-2 expression in human alveolar epithelium via STAT3 but not NF-κB signaling pathway," Inflammation, vol. 38, no. 3, pp. 1191-1200, 2015.
84. M. J. McGeachy and S. J. McSorley, "Microbial-induced Th17: superhero or supervillain?" The Journal of Immunology, vol. 189, no. 7, pp. 3285-3291, 2012.
85. F. Maione, N. Paschalidis, N. Mascolo, N. Dufton, M. Perretti, and F. D'Acquisto, "Interleukin 17 sustains rather than induces inflammation," Biochemical Pharmacology, vol. 77, no. 5, pp. 878-887, 2009.
86. + regulatory T cells," The Journal of Immunology, vol. 180, no. 1, pp. 122-129, 2008.
87. L. Maggi, V. Santarlasci, M. Capone et al., "CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC," European Journal of Immunology, vol. 40, no. 8, pp. 2174-2181, 2010.
88. + T cell precursor," The Journal of Experimental Medicine, vol. 205, no. 8, pp. 1903-1916, 2008.
89. C. H. Kim, "Migration and function of Th17 cells," Inflammation and Allergy-Drug Targets, vol. 8, no. 3, pp. 221-228, 2009.
90. E. V. Acosta-Rodriguez, L. Rivino, J. Geginat et al., "Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells," Nature Immunology, vol. 8, no. 6, pp. 639-646, 2007.
91. R. Ramesh, L. Kozhaya, K. McKevitt et al., "Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids," Journal of Experimental Medicine, vol. 211, no. 1, pp. 89-104, 2014.
92. F. Annunziato, L. Cosmi, V. Santarlasci et al., "Phenotypic and functional features of human Th17 cells," The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849-1861, 2007.
93. C. J. Cohen, S. Q. Crome, K. G. MacDonald, E. L. Dai, D. L. Mager, and M. K. Levings, "Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci," Journal of Immunology, vol. 187, no. 11, pp. 5615-5626, 2011.
94. F. Sallusto, C. E. Zielinski, and A. Lanzavecchia, "HumanTh17 subsets," European Journal of Immunology, vol. 42, no. 9, pp. 2215-2220, 2012.
95. C. S. Lindestam Arlehamn, A. Gerasimova, F. Mele et al., "Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset," PLoS Pathogens, vol. 9, no. 1, Article ID e1003130, 2013.
96. H17 cells in the absence of TGF-β signalling," Nature, vol. 467, no. 7318, pp. 967-971, 2010.
97. E. Esplugues, S. Huber, N. Gagliani et al., "Control of TH17 cells occurs in the small intestine," Nature, vol. 475, no. 7357, pp. 514-518, 2011.
98. Y. Lee, A. Awasthi, N. Yosef et al., "Induction and molecular signature of pathogenic TH17 cells," Nature Immunology, vol. 13, no. 10, pp. 991-999, 2012.
99. H-17 cell-mediated pathology," Nature Immunology, vol. 8, no. 12, pp. 1390-1397, 2007.
100. M. Umemura, A. Yahagi, S. Hamada et al., "IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guérin infection," Journal of Immunology, vol. 178, no. 6, pp. 3786-3796, 2007.
101. R. Gopal, Y. Lin, N. Obermajer et al., "IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination," European Journal of Immunology, vol. 42, no. 2, pp. 364-373, 2012.
102. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge," Nature Immunology, vol. 8, no. 4, pp. 369-377, 2007.
103. K. L. Griffiths, A. A. Pathan, A.M. Minassian et al., "Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A," PLoS ONE, vol. 6, no. 8, Article ID e23463, 2011.
104. S. A. Khader, J. E. Pearl, K. Sakamoto et al., "IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available," Journal of Immunology, vol. 175, no. 2, pp. 788-795, 2005.
105. R. Gopal, L. Monin, S. Slight et al., "Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection," PLoS Pathogens, vol. 10, no. 5, Article ID e1004099, 2014.
106. K. Dheda, J.-S. Chang, S. Lala, J. F. Huggett, A. Zumla, and G. A. W. Rook, "Gene expression of IL17 and IL23 in the lungs of patients with active tuberculosis," Thorax, vol. 63, no. 6, pp. 566-568, 2008.
107. + T cell subsets contribute to the human anti-mycobacterial immune response," Journal of Immunology, vol. 180, no. 3, pp. 1962-1970, 2008.
108. Y.-C. Chen, C.-H. Chin, S.-F. Liu et al., "Prognostic values of serumIP-10 and IL-17 in patients with pulmonary tuberculosis," Disease Markers, vol. 31, no. 2, pp. 101-110, 2011.
109. J. O. Jurado, V. Pasquinelli, I. B. Alvarez et al., "IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease," Journal of Leukocyte Biology, vol. 91, no. 6, pp. 991-1002, 2012.
110. J. I. Basile, L. J. Geffner, M. M. Romero et al., "Outbreaks of Mycobacterium tuberculosis MDR strains induce high IL-17 Tcell response in patients with MDR tuberculosis that is closely associated with high antigen load," Journal of Infectious Diseases, vol. 204, no. 7, pp. 1054-1064, 2011.
111. E. B. Eruslanov, I. V. Lyadova, T. K. Kondratieva et al., "Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice," Infection and Immunity, vol. 73, no. 3, pp. 1744-1753, 2005.
112. C. Keller, R. Hoffmann, R. Lang, S. Brandau, C. Hermann, and S. Ehlers, "Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes," Infection and Immunity, vol. 74, no. 7, pp. 4295-4309, 2006.
113. A. Dorhoi, C. Desel, V. Yeremeev et al., "The adaptor molecule CARD9 is essential for tuberculosis control," The Journal of Experimental Medicine, vol. 207, no. 4, pp. 777-792, 2010.
114. + immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice," The Journal of Immunology, vol. 192, no. 10, pp. 4718-4727, 2014.
115. J. K. Knaul, S. Jörg, D. Oberbeck-Mueller et al., "Lungresidingmyeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis," American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 9, pp. 1053-1066, 2014.
116. A. Dorhoi and S. H. Kaufmann, "Versatilemyeloid cell subsets contribute to tuberculosis-associated inflammation," European Journal of Immunology, vol. 45, no. 8, pp. 2191-2202, 2015.
117. N. D. Marín, S. C. París, M. Rojas, and L. F. García, "Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis," Clinical and Vaccine Immunology, vol. 19, no. 10, pp. 1667-1676, 2012.
118. S. Babu, S. Q. Bhat, N. P. Kumar, V. Kumaraswami, and T. B. Nutman, "Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results," Journal of Infectious Diseases, vol. 201, no. 1, pp. 20-31, 2010.
119. Q. Li, J. Li, J. Tian et al., "IL-17 and IFN-γ production in peripheral blood following BCG vaccination and Mycobacterium tuberculosis infection in human," European Review for Medical and Pharmacological Sciences, vol. 16, no. 14, pp. 2029-2036, 2012.
120. S. N. Harbour, C. L. Maynard, C. L. Zindl, T. R. Schoeb, and C. T. Weaver, "Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis," Proceedings of the National Academy of Sciences, vol. 112, no. 22, pp. 7061-7066, 2015.
121. C. L. Arlehamn, G. Seumois, A. Gerasimova et al., "Transcriptional profile of tuberculosis antigen-specific T cells reveals novelmultifunctional features," The Journal of Immunology, vol. 193, no. 6, pp. 2931-2940, 2014.
122. K. Matthews, K. A. Wilkinson, B. Kalsdorf et al., "Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis," Tuberculosis, vol. 91, no. 6, pp. 587-593, 2011.
123. C. Riou, C. M. Gray, M. Lugongolo et al., "Asubset of circulating bloodmycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion," PLoS ONE, vol. 9, no. 7, Article ID e102178, 2014.
124. T. H. Watts, "THF/TNFR family members in costimulation of T cell responses," Annual Review of Immunology, vol. 23, no. 1, pp. 23-68, 2005.
125. - cells are induced by antigen and evolve through extensive rounds of division," International Immunology, vol. 11, no. 7, pp. 1027-1033, 1999.
126. + CTLs ex vivo," The Journal of Immunology, vol. 168, no. 11, pp. 5954-5958, 2002.
127. R. D. Fritsch, X. Shen, G. P. Sims, K. S. Hathcock, R. J. Hodes, and P. E. Lipsky, "Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27," The Journal of Immunology, vol. 175, no. 10, pp. 6489-6497, 2005.
128. M. A. Nolte, R. W. van Olffen, K. P. J. M. van Gisbergen, and R. A. W. van Lier, "Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology," Immunological Reviews, vol. 229, no. 1, pp. 216-231, 2009.
129. D. A. Kaveh, V. S. Bachy, R. G. Hewinson, and P. J. Hogarth, "Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 TEM cells which expand following virulent mycobacterial challenge," PLoS ONE, vol. 6, no. 6, Article ID e21566, 2011.
130. I. V. Lyadova, S. Oberdorf, M. A. Kapina, A. S. Apt, S. L. Swain, and P. C. Sayles, "CD4 T cells producing IFN-γ in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype," Clinical & Experimental Immunology, vol. 138, no. 1, pp. 21-29, 2004.
131. high precursors in situ, produce IFN-γ, and protect the host against tuberculosis infection," The Journal of Immunology, vol. 178, no. 2, pp. 976-985, 2007.
132. M. Streitz, L. Tesfa, V. Yildirim et al., "Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis," PLoS ONE, vol. 2, no. 8, article e735, 2007.
133. + T cells correlates with persistent active tuberculosis," Journal of Clinical Immunology, vol. 30, no. 4, pp. 566-573, 2010.
134. A. Schuetz, A. Haule, K. Reither et al., "Monitoring CD27 expression to evaluate mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo," PLoS ONE, vol. 6, no. 11, Article ID e27284, 2011.
135. D. Portevin, F. Moukambi, P. Clowes et al., "Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-ofconcept study," The Lancet Infectious Diseases, vol. 14, no. 10, pp. 931-938, 2014.
136. E. Petruccioli, L. Petrone, V. Vanini et al., "Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis," Journal of Infection, 2015.
137. + T cells," Blood, vol. 101, no. 7, pp. 2711-2720, 2003.
138. + T cells between active and latent tuberculosis infection," Clinical Immunology, vol. 159, no. 1, pp. 37-46, 2015.
139. T. Adekambi, C. C. Ibegbu, S. Cagle et al., "Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response," The Journal of Clinical Investigation, vol. 125, no. 5, pp. 1827-1838, 2015.
140. + T cell responses discriminate between latent infection and active disease," Nature Medicine, vol. 17, pp. 372-376, 2011.
141. + T cells are functionally and phenotypically different between latent infection and active disease," European Journal of Immunology, vol. 43, no. 6, pp. 1568-1577, 2013.
142. V. Rozot, A. Patrizia, S. Vigano et al., "Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis," Clinical Infectious Diseases, vol. 60, no. 3, pp. 432-437, 2015.
143. C. L. Day, D. A. Abrahams, L. Lerumo et al., "Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated withmycobacterial load," The Journal of Immunology, vol. 187, no. 5, pp. 2222-2232, 2011.
144. + T cells correlate with active Mycobacterium tuberculosis infection," European Journal of Immunology, vol. 40, no. 8, pp. 2211-2220, 2010.
145. E. Petruccioli, L. Petrone, V. Vanini et al., "IFNγ/TNFα specificcells and effector memory phenotype associate with active tuberculosis," Journal of Infection, vol. 66, no. 6, pp. 475-486, 2013.
146. D. Chesov, C. Lange, F. Daduna et al., "Combined antigenspecific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection," PLoS ONE, vol. 10, no. 3, Article IDe0120006, 2015.
147. K. M. Pollock, H. S. Whitworth, D. J. Montamat-Sicotte et al., "T-cell immunophenotyping distinguishes active from latent tuberculosis," The Journal of Infectious Diseases, vol. 208, no. 6, pp. 952-968, 2013.
148. D.H. Canaday, S. Sridaran, P. Van Epps et al., "CD4+Tcell polyfunctional profile in HIV-TB coinfection are similar between individuals with latent and active TB infection," Tuberculosis, vol. 95, no. 4, pp. 470-475, 2015.